API | Ebastine

Ebastine (kestine) Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Ebastine is a H1 antihistamine with low potential for causing drowsiness. ^Wikipedia

Chemistry

SMILES: CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
InChIKey: MJJALKDDGIKVBE-UHFFFAOYSA-N
Mol. Mass: 469.67
ALogP: 7.22 Partition coefficient
ChEMBL Molecule:
ebastine

More Chemistry

Pharmacology

Mechanisms of Action:
- Histamine H1 receptor (Homo sapiens) ^UniProt
- Histamine H1 receptor (Bos taurus) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Oral
Pro Drug: No

Organizations (4)

Research & Development (4)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (4)

Approved Indications (1)

Rhinitis, Allergic

Experimental Indications - Clinical Trial Phases 1-4 (3)

Hypersensitivity, Immediate ()

Irritable Bowel Syndrome (Phase 4)

Urticaria (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial Organizations: 4

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue